[ad_1]
FDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.
[ad_2]
, 2024-06-04 23:53:33
Source link
FDA panel votes against MDMA for PTSD, setting up hurdle to approval
previous post
